Optiver Holding’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-94,949
| Closed | -$429K | – | 2410 |
|
|
2025
Q4 | $429K | Buy |
94,949
+90,231
| +1,912% | +$462K | ﹤0.01% | 600 |
|
|
2025
Q3 | $25.4K | Buy |
4,718
+1
| +0% | +$5 | ﹤0.01% | 905 |
|
|
2025
Q2 | $25.6K | Hold |
4,717
| – | – | ﹤0.01% | 769 |
|
|
2025
Q1 | $13.1K | Buy |
4,717
+4,527
| +2,383% | +$15.8K | ﹤0.01% | 814 |
|
|
2024
Q4 | $648 | Buy |
+190
| New | +$548 | ﹤0.01% | 1006 |
|
|
2023
Q4 | – | Sell |
-6,844
| Closed | -$46.7K | – | 506 |
|
|
2023
Q3 | $46.7K | Buy |
6,844
+6,571
| +2,407% | +$58K | ﹤0.01% | 461 |
|
|
2023
Q2 | $2.85K | Buy |
273
+113
| +71% | +$1.01K | ﹤0.01% | 439 |
|
|
2023
Q1 | $1.11K | Buy |
+160
| New | +$1.4K | ﹤0.01% | 492 |
|
|
2022
Q2 | – | Sell |
-79
| Closed | -$2K | – | 385 |
|
|
2022
Q1 | $2K | Buy |
79
+25
| +46% | +$499 | ﹤0.01% | 485 |
|
|
2021
Q4 | $3K | Buy |
54
+17
| +46% | +$684 | ﹤0.01% | 821 |
|
|
2021
Q3 | $2K | Sell |
37
-305
| -89% | -$18.4K | ﹤0.01% | 685 |
|
|
2021
Q2 | $25K | Buy |
+342
| New | +$34.2K | ﹤0.01% | 340 |
|
Optiver Holding's CVAC Position: Q1 2026 in Review
Optiver Holding sold out of CureVac (CVAC) in Q1 2026, closing a stake of 94,949 shares — an estimated $429K sold.
Optiver Holding first reported a position in CVAC in Q2 2021 and held it in 12 quarters. The position peaked at $429K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Optiver Holding reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Optiver Holding sold 94,949 CureVac shares in Q1 2026, an estimated $429K.
- Optiver Holding first reported a position in CureVac in Q2 2021 and held it in 12 quarters.
- Optiver Holding's CureVac position peaked at $429K in Q4 2025.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.